The trial (NCT06053840) enrolled 100 adult patients who received chloral hydrate treatment over 14 days and came from primary and secondary care sites. Patients were closely monitored by a virtual ...

Announced strategic financing with Arena Investors, providing access to up to $59.0 million USD in gross proceeds to Incannex Announced positive top-line results from our Phase 2 proof-of-concept clin ...

Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

When working with clinical trial data, converting raw data into the standardized Study Data Tabulation Model (SDTM) format is a crucial step.

Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...

A number of recent clinical trials have suggested that gene therapy could help treat diseases of the eye that cause vision ...

Durham, North Carolina Tuesday, October 1, 2024, 18:00 Hrs [IST] ...

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced the appointment of Dr. Daniel Von Hoff to ...

Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical ...

The trial's primary goal is to assess the efficacy, safety and tolerability of daily oral doses of SCI-110 in adults aged 18 ...

IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. | IGM Biosciences ended last year ...

Platelet-rich plasma (PRP) treatment involves taking blood from a patient and harvesting certain components of that blood — ...